Compagnie Lombard Odier S Cm A Viking Therapeutics, Inc. Transaction History
Compagnie Lombard Odier S Cm A
- $7.2 Billion
- Q2 2025
A detailed history of Compagnie Lombard Odier S Cm A transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Compagnie Lombard Odier S Cm A holds 25,245 shares of VKTX stock, worth $1.01 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
25,245
Previous 20,245
24.7%
Holding current value
$1.01 Million
Previous $488,000
36.89%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding VKTX
# of Institutions
453Shares Held
66.1MCall Options Held
8.28MPut Options Held
3.44M-
Vanguard Group Inc Valley Forge, PA10.2MShares$405 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$240 Million0.01% of portfolio
-
State Street Corp Boston, MA4.06MShares$162 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY3.13MShares$125 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.12MShares$124 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $3.06B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...